Emmaus Life Sciences, Inc.
(Other OTC/NBB : EMMA)

( )
EMMA After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
PFEPfizer Inc. -1.39%34.030.9%$1163.63m
JNJJohnson & Johnson -0.12%142.810.7%$1084.56m
BMYBristol-Myers Squibb Co. 0.18%60.301.0%$985.23m
MRKMerck & Co., Inc. -1.11%78.700.7%$830.95m
ABBVAbbVie, Inc. 0.41%99.421.9%$788.32m
LLYEli Lilly & Co. -0.09%166.741.1%$696.31m
VXRTVaxart, Inc. 37.73%8.870.0%$300.02m
AZNAstraZeneca Plc -1.15%53.481.2%$295.19m
RPRXRoyalty Pharma Plc 2.04%47.050.1%$233.45m
NVSNovartis AG -0.75%87.800.2%$155.51m
RGENRepligen Corp. -1.94%124.147.1%$117.72m
GSKGlaxoSmithKline Plc -1.56%40.370.2%$117.39m
NVONovo Nordisk A/S -1.31%65.060.1%$94.47m
RETAReata Pharmaceuticals, Inc. -2.99%155.643.4%$81.74m
SNYSanofi -1.48%51.430.2%$73.80m

Company Profile

Emmaus Life Sciences, Inc. is a commercial-stage biopharmaceutical company. It engages in the discovery, development, marketing and sale of innovative treatments and therapies, including those in the rare and orphan disease categories. The company is headquartered in Torrance, CA.